Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Clinical trial NCT03055013 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03055013
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage II Renal Cell Cancer AJCC v7 Stage III Renal Cell Cancer AJCC v7 Unclassified Renal Cell Carcinoma

Start date: 2017-04-28
Primary completion: 2023-05-24
Enrollment: 819

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.